Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Adeza Biomedical Corp (ADZA) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Adeza Biomedical Corp. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 902482.
Total stock buying since 2005: $35,269,728.
Total stock sales since 2005: $4,108,612.
Total stock option exercises since 2005: $37,965.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2007 | 1,469,572 | $35,269,728 | 0 | $0 | 0 | $0 |
| 2006 | 0 | $0 | 75,926 | $1,325,066 | 38,540 | $37,383 |
| 2005 | 0 | $0 | 172,967 | $2,783,546 | 600 | $582 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2007-03 | 1,469,572 | $35,269,728 | 0 | $0 | 0 | $0 |
| 2006-12 | 0 | $0 | 1,200 | $18,000 | 0 | $0 |
| 2006-11 | 0 | $0 | 29,890 | $440,578 | 29,890 | $28,993 |
| 2006-10 | 0 | $0 | 1,200 | $19,791 | 0 | $0 |
| 2006-09 | 0 | $0 | 1,200 | $20,415 | 0 | $0 |
| 2006-08 | 0 | $0 | 1,200 | $19,782 | 0 | $0 |
| 2006-04 | 0 | $0 | 4,968 | $105,743 | 1,050 | $1,018 |
| 2006-03 | 0 | $0 | 29,228 | $548,643 | 1,200 | $1,164 |
| 2006-02 | 0 | $0 | 2,560 | $56,606 | 3,200 | $3,104 |
| 2006-01 | 0 | $0 | 4,480 | $95,508 | 3,200 | $3,104 |
| 2005-12 | 0 | $0 | 5,193 | $97,114 | 600 | $582 |
| 2005-11 | 0 | $0 | 5,477 | $94,434 | 0 | $0 |
| 2005-08 | 0 | $0 | 162,297 | $2,591,998 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2007-03-31 | Augusta Medical Corp (10% Owner) | Buy | 1,469,572 | 24.00 | 35,269,728 |
| 2006-12-06 | Hussa Robert O (VP Research & Development) | Sale | 1,200 | 15.00 | 18,000 |
| 2006-11-30 | Sacco Marian E (VP Sales & Marketing) | Sale | 29,890 | 14.74 | 440,578 |
| 2006-11-30 | Sacco Marian E (VP Sales & Marketing) | Option Ex | 29,890 | .97 | 28,993 |
| 2006-10-02 | Hussa Robert O (VP Research & Development) | Sale | 1,200 | 16.49 | 19,791 |
| 2006-09-01 | Hussa Robert O (VP Research & Development) | Sale | 1,200 | 17.01 | 20,415 |
| 2006-08-08 | Hussa Robert O (VP Research & Development) | Sale | 1,200 | 16.48 | 19,782 |
| 2006-04-03 | Hussa Robert O (VP Research & Development) | Sale | 4,968 | 21.29 | 105,743 |
| 2006-04-03 | Hussa Robert O (VP Research & Development) | Option Ex | 1,050 | .97 | 1,018 |
| 2006-03-10 | Anderson Emory V. (President and CEO) | Sale | 5,083 | 19.13 | 97,222 |
| 2006-03-09 | Anderson Emory V. (President and CEO) | Sale | 5,085 | 18.65 | 94,814 |
| 2006-03-08 | Anderson Emory V. (President and CEO) | Sale | 5,085 | 18.61 | 94,621 |
| 2006-03-07 | Anderson Emory V. (President and CEO) | Sale | 5,085 | 18.92 | 96,223 |
| 2006-03-06 | Hussa Robert O (VP Research & Development) | Sale | 3,805 | 18.66 | 71,005 |
| 2006-03-06 | Hussa Robert O (VP Research & Development) | Option Ex | 1,200 | .97 | 1,164 |
| 2006-03-06 | Anderson Emory V. (President and CEO) | Sale | 5,085 | 18.64 | 94,758 |
| 2006-02-01 | Hussa Robert O (Development) | Sale | 2,560 | 22.11 | 56,606 |
| 2006-02-01 | Hussa Robert O (Development) | Option Ex | 3,200 | .97 | 3,104 |
| 2006-01-03 | Hussa Robert O (Development) | Sale | 3,840 | 21.57 | 81,336 |
| 2006-01-03 | Hussa Robert O (Development) | Option Ex | 3,200 | .97 | 3,104 |
| 2005-12-30 | Sacco Marian E (VP Sales & Marketing) | Option Ex | 600 | .97 | 582 |
| 2005-12-01 | Hussa Robert O (Development) | Sale | 5,193 | 18.70 | 97,114 |
| 2005-11-04 | Hussa Robert O (Development) | Sale | 5,477 | 17.24 | 94,434 |
| 2005-08-29 | Hussa Robert O (Development) | Sale | 10,000 | 16.57 | 165,710 |
| 2005-08-23 | Credit Suisse First Boston/ (Other) | Sale | 89,603 | 15.87 | 1,422,178 |
| 2005-08-10 | Anderson Emory V. (President and CEO) | Sale | 59,241 | 15.91 | 942,820 |
| 2005-08-08 | Hussa Robert O (Development) | Sale | 3,453 | 17.75 | 61,290 |
Insider trading activities including stock purchases, stock sales, and option exercises of ADZA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Adeza Biomedical Corp (symbol ADZA, CIK number 902482) see the Securities and Exchange Commission (SEC) website.